Volume 19, Number 7—July 2013
Dispatch
Babesia microti Infection, Eastern Pennsylvania, USA
Marcela E. Perez Acosta
, Peter T. Ender, Erin M. Smith, and Jeffrey A. Jahre
, Peter T. Ender, Erin M. Smith, and Jeffrey A. Jahre
Table
Clinical and laboratory data for 3 patients with babesiosis at dates of admission, diagnosis of babesiosis and discharge, eastern Pennsylvania, USA*
| Characteristic |
Patient 1 |
Patient 2 |
Patient 3 |
||||
|---|---|---|---|---|---|---|---|
| Date | 2011 Aug 18 | 2011 Aug 25 | 2012 Jun 8 | 2012 Jun 12 | 2012 Jun 16 | 2012 Jun 26 | 2012 Jul 11 |
| Temperature, °C | 38.7 | 35.7 | 36.8 | 37.2 | 36.1 | 37.8 | 37.2 |
| Hematocrit, % | 43.1 | 28.3 | 26.0 | 27.4 | 30.7 | 43.3 | 32.9 |
| Leukocyte count, × 109/L | 9.87 | 6.43 | 2.94 | 5.47 | 3.36 | 7.93 | 10.6 |
| Platelet count, × 109/L | 45 | 197 | 46 | 68 | 68 | 41 | 74 |
| Total bilirubin, mg/dL† | 4.77 | 0.88 | 3.05 | NA | NA | 2.0 | 2.48 |
| Parasitemia level, % | 10.0 | 1.2 | NA | 1.4 | 0.1 | 0.4 | 0.0 |
| Creatinine, mg/dL‡ | 1.9 | 1.1 | 1.47 | 1.12 | NA | 1.16 | 0.95 |
*NA, not available.
†Reference range 0.20–1.00 mg/dL.
‡Reference range 0.60–1.30 mg/dL.
Page created: June 17, 2013
Page updated: June 17, 2013
Page reviewed: June 17, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.